Market capitalization | $10.43b |
Enterprise Value | $45.18b |
PER (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.31 |
P/S ratio (TTM) P/S ratio | 0.07 |
P/B ratio (TTM) P/B ratio | 0.77 |
Dividend yield | 15.87% |
Last dividend (FY23) | $1.92 |
Activate alerts on the share price, dividend yield, valuation (e.g. P/E ratio or EV/sales) or strategy scores and sit back and relax.
22 Analysts have issued a Walgreens Boots Alliance forecast:
22 Analysts have issued a Walgreens Boots Alliance forecast:
Aug '23 |
+/-
%
|
||
Turnover | 139,081 139,081 |
5%
5%
|
|
Gross income | 24,815 24,815 |
6%
6%
|
|
EBITDA | 5,244 5,244 |
10%
10%
|
EBIT (operating result) EBIT | 2,987 2,987 |
8%
8%
|
Net profit | -3,080 -3,080 |
171%
171%
|
Figures in millions USD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.
Head office | United States |
CEO | Timothy Wentworth |
Employees | 331,000 |
Founded | 1909 |
Website | www.walgreensbootsalliance.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.